following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.
.
.
.
"if the battery in a mechanical mod over-discharges and the device doesn't contain enough air holes to allow the battery to vent, there is a risk of explosion."
.